FOLH1 and Familial prostate cancer: However, despite this limitation, the spatial patterns of biological effects observed from PSMA-targeted radiopharmaceutical therapy across three distinct prostate cancer tissues (PC1, PC2, and PC3) were consistent with prostate cancer cell fractions as depicted in Figure S3B.